Biogen (BIIB) PT Lowered to $300 at H.C. Wainwright

March 25, 2019 7:49 AM
H.C. Wainwright analyst Andrew Fein lowered the price target on Biogen (NASDAQ: BIIB) to $300.00 (from $363.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst PT Change

Next Articles